Ranibizumab for the treatment of degenerative ocular conditions
Magdalini Triantafylla,1 Horace F Massa,2 Doukas Dardabounis,1 Zisis Gatzioufas,2 Vassilios Kozobolis,1 Konstantinos Ioannakis,1 Irfan Perente,1,3 Georgios D Panos1,21Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupol...
Guardado en:
Autores principales: | Triantafylla M, Massa HF, Dardabounis D, Gatzioufas Z, Kozobolis V, Ioannakis K, Perente I, Panos GD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/888ee8ee09a3493180f43a1315615dda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart MW
Publicado: (2013) -
Treatment of age-related macular degeneration: focus on ranibizumab
por: Martin S Spitzer, et al.
Publicado: (2008) -
Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama K, et al.
Publicado: (2012) -
Current perspectives on ranibizumab
por: Dedania VS, et al.
Publicado: (2015) -
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello F, et al.
Publicado: (2011)